{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:12:47Z","timestamp":1780060367016,"version":"3.54.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.japh.2018.06.014","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T17:59:19Z","timestamp":1532109559000},"page":"534-539.e4","source":"Crossref","is-referenced-by-count":37,"title":["An evaluation of a potential calcium channel blocker\u2013lower-extremity edema\u2013loop diuretic prescribing cascade"],"prefix":"10.1016","volume":"58","author":[{"given":"Scott Martin","family":"Vouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"van Tuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schootman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2018.06.014_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2013.01.002","article-title":"Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study","volume":"64","author":"Wagg","year":"2013","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.japh.2018.06.014_bib3","first-page":"CD009096","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension","author":"Li","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.japh.2018.06.014_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871525713666150310111554","article-title":"Calcium channel blockers in the management of hypertension in the elderly","volume":"12","author":"Caballero-Gonzalez","year":"2015","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"7","key":"10.1016\/j.japh.2018.06.014_bib5","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","article-title":"Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate\u2013a meta-analysis of randomized trials","volume":"29","author":"Makani","year":"2011","journal-title":"J\u00a0Hypertens"},{"issue":"23","key":"10.1016\/j.japh.2018.06.014_bib6","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11886-002-0110-9","article-title":"Vasodilatory edema: a common side effect of antihypertensive therapy","volume":"4","author":"Messerli","year":"2002","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib8","first-page":"330","article-title":"Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance","volume":"5","author":"Weir","year":"2003","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"11","key":"10.1016\/j.japh.2018.06.014_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0895-7061(02)03087-X","article-title":"Pedal edema\u2014not all dihydropyridine calcium antagonists are created equal","volume":"15","author":"Messerli","year":"2002","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1016\/j.japh.2018.06.014_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.jhh.1001201","article-title":"Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension","volume":"15","author":"Pedrinelli","year":"2001","journal-title":"J\u00a0Hum Hypertens"},{"issue":"4","key":"10.1016\/j.japh.2018.06.014_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1524-6175.2003.02402.x","article-title":"Calcium channel blocker-related peripheral edema: can it be resolved?","volume":"5","author":"Sica","year":"2003","journal-title":"J\u00a0Clin Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2018.06.014_bib12","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00005344-198710001-00023","article-title":"Microvascular mechanisms involved in calcium antagonist edema formation","volume":"10","author":"Gustafsson","year":"1987","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"7115","key":"10.1016\/j.japh.2018.06.014_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","article-title":"Optimising drug treatment for elderly people: the prescribing cascade","volume":"315","author":"Rochon","year":"1997","journal-title":"BMJ"},{"issue":"10081","key":"10.1016\/j.japh.2018.06.014_bib14","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","article-title":"The prescribing cascade revisited","volume":"389","author":"Rochon","year":"2017","journal-title":"Lancet"},{"issue":"9 Pt 1","key":"10.1016\/j.japh.2018.06.014_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0895-7061(01)02178-1","article-title":"Vasodilatory edema: a common side effect of antihypertensive therapy","volume":"14","author":"Messerli","year":"2001","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.japh.2018.06.014_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0167-5273(91)90007-C","article-title":"Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema","volume":"30","author":"Salmasi","year":"1991","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0300-2977(95)90003-9","article-title":"Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward","volume":"44","author":"van Kraaij","year":"1994","journal-title":"Neth J Med"},{"issue":"2","key":"10.1016\/j.japh.2018.06.014_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40266-013-0145-1","article-title":"Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence","volume":"31","author":"Tannenbaum","year":"2014","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00002512-200825060-00002","article-title":"Management of acute renal failure in the elderly patient: a clinician's guide","volume":"25","author":"Cheung","year":"2008","journal-title":"Drugs Aging"},{"issue":"9","key":"10.1016\/j.japh.2018.06.014_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1524-6175.2004.03789.x","article-title":"Diuretic-related side effects: development and treatment","volume":"6","author":"Sica","year":"2004","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.3256","article-title":"New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home","volume":"21","author":"Berry","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ageing\/29.6.489","article-title":"Inappropriate use of loop diuretics in elderly patients","volume":"29","author":"Kelly","year":"2000","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jamda.2013.02.002","article-title":"Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs","volume":"14","author":"Wehling","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"3","key":"10.1016\/j.japh.2018.06.014_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1715163516640811","article-title":"Prescribing cascade in an elderly woman","volume":"149","author":"Nguyen","year":"2016","journal-title":"Can Pharm J (Ott)"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.annemergmed.2012.07.010","article-title":"Understanding and interpreting the National Hospital Ambulatory Medical Care Survey: key questions and answers","volume":"60","author":"McCaig","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.japh.2018.06.014_bib26","series-title":"Trend analysis using NAMCS and NHAMCS drug data. Ambulatory Health Care Data","author":"Centers for Disease Control and Prevention","year":"2015"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.japh.2018.06.014_bib28","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.0000016176.16042.2F","article-title":"Resistant hypertension: comparing hemodynamic management to specialist care","volume":"39","author":"Taler","year":"2002","journal-title":"Hypertension"},{"issue":"5\u00a0Pt 1","key":"10.1016\/j.japh.2018.06.014_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjhyper.2004.11.021","article-title":"Resistant hypertension revisited: a comparison of two university-based cohorts","volume":"18","author":"Garg","year":"2005","journal-title":"Am J Hypertens"},{"issue":"16","key":"10.1016\/j.japh.2018.06.014_bib31","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.160.16.2429","article-title":"New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice","volume":"160","author":"Cohn","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.japh.2018.06.014_bib32","article-title":"Considerations and techniques for analyzing domains of complex survey data","author":"Lewis","year":"2013","journal-title":"SAS Global Forum"},{"key":"10.1016\/j.japh.2018.06.014_bib33","article-title":"Try, try again: replication-based variance estimation methods for survey data analysis in SAS 9.2","author":"Mukhopadhyay","year":"2008","journal-title":"SAS Global Forum"},{"issue":"1","key":"10.1016\/j.japh.2018.06.014_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"12","key":"10.1016\/j.japh.2018.06.014_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/11597040-000000000-00000","article-title":"Validity of the Medication-based Disease Burden Index compared with the Charlson Comorbidity Index and the Cumulative Illness Rating Scale for geriatrics: a cohort study","volume":"28","author":"Beloosesky","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.japh.2018.06.014_bib36","series-title":"Effects of the Affordable Care Act through","author":"Gray","year":"2015"},{"issue":"2","key":"10.1016\/j.japh.2018.06.014_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.24926\/iip.v8i2.524","article-title":"Drug-induced adverse events and prescribing cascades in older adults: pharmacy stakeholder survey","volume":"8","author":"Vouri","year":"2017","journal-title":"Inov Pharm"},{"key":"10.1016\/j.japh.2018.06.014_bib38","article-title":"2012 Medicare Part D medication therapy management (MTM) programs","author":"Tudor","year":"2012","journal-title":"Fact sheet"},{"key":"10.1016\/j.japh.2018.06.014_bib39","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"5","key":"10.1016\/j.japh.2018.06.014_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0149-2918(97)80046-X","article-title":"Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT)","volume":"19","author":"Toal","year":"1997","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.japh.2018.06.014_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9149(00)01491-0","article-title":"Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension","volume":"87","author":"Kloner","year":"2001","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.japh.2018.06.014_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9149(96)00781-3","article-title":"Enalapril-Felodipine ER Factorial Study Group. Combined enalapril and felodipine extended release (ER) for systemic hypertension","volume":"79","author":"Gradman","year":"1997","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.japh.2018.06.014_bib43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9149(02)03154-5","article-title":"Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris","volume":"91","author":"Pepine","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.japh.2018.06.014_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3810\/pgm.2009.03.1972","article-title":"Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4\u00a0\u00d7 4 factorial study","volume":"121","author":"Littlejohn","year":"2009","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.japh.2018.06.014_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"Philipp","year":"2007","journal-title":"Clin Ther"},{"issue":"9489","key":"10.1016\/j.japh.2018.06.014_bib46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"issue":"9426","key":"10.1016\/j.japh.2018.06.014_bib47","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319118302516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319118302516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:42:28Z","timestamp":1536014548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319118302516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1544319118302516"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2018.06.014","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}